We only have a few drugs that treat Alzheimer's that have been approved for use within Canada within the last six or seven years. We generally see this all across mental health drugs, including drugs for Alzheimer's. So we don't have, let's say, a basket of ten to look at. We're looking at maybe one or two. But when we look at those one or two drugs to treat Alzheimer's, unfortunately, what we see is that most other countries in the OECD--the other 28 countries--provide some form of public coverage for those drugs.
On November 30th, 2010. See this statement in context.